ARTICLE | Financial News
Rejuvenon raises $37 million
June 23, 2004 7:00 AM UTC
Rejuvenon (The Woodlands, Texas) raised $37 million in a series B round led by Schroder Ventures Life Sciences. Rejuvenon in-licenses and develops small molecules to treat cancer and metabolic diseases. The company's RC1291 ghrelin mimetic is in Phase I testing to treat cancer cachexia. ...